Denise M. Bohnert is CCO at AMEDISYS INC (AMED). They have made 5 open-market trades across 1 company since 2020, most recently 2025-08-14.
CIK 0001787283
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AMED | 3,468 | $350K |
Shares reported on the most recent Form 4, priced at the 2025-08-14 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AMED | SELL | 2022-06-23 | 2022-06-27 | $115.00 | $64K | +4.9% | +12.0% | -9.3% |
| AMED | SELL · 10b5-1 | 2021-02-25 | 2021-03-01 | $274.44 | $19K | +1.4% | +2.6% | +0.0% |
| AMED | SELL · 10b5-1 | 2021-02-22 | 2021-02-23 | $291.48 | $37K | -14.0% | -4.6% | -7.8% |
| AMED | SELL | 2021-01-25 | 2021-01-27 | $314.41 | $285K | +6.1% | -11.8% | -0.9% |
| AMED | SELL | 2021-01-20 | 2021-01-22 | $300.84 | $316K | -7.2% | -9.5% | -10.0% |
| AMED | SELL | 2020-07-29 | 2020-07-31 | $220.00 | $80K | -0.3% | +5.5% | +9.4% |
| AMED | SELL | 2020-06-02 | 2021-04-22 | $190.36 | $100K | -8.2% | -8.3% | -9.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.